Clinical and Dermoscopic Factors for the Identification of Aggressive Histologic Subtypes of Basal Cell Carcinoma.

basal cell carcinoma dermoscopy infiltrative nodular subtype superficial

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 17 11 2020
accepted: 22 12 2020
entrez: 8 3 2021
pubmed: 9 3 2021
medline: 9 3 2021
Statut: epublish

Résumé

Infiltrative basal cell carcinoma (BCC) has a higher risk for post-surgical recurrence as compared to the most common low-aggressive superficial and nodular BCC. Independent diagnostic criteria for infiltrative BCC diagnosis have not been still defined. Improving the pre-surgical recognition of infiltrative BCC might significantly reduce the risk of incomplete excision and recurrence. The aim of this study is to define clinical and dermoscopic criteria that can differentiate infiltrative BCC from the most common low-aggressive superficial and nodular BCC. Clinical and dermoscopic images of infiltrative, superficial, and nodular BCC were retrospectively retrieved from our database and jointly evaluated by two experienced dermoscopists, blinded for the histologic subtype. Pairwise comparisons between the three histologic subtypes were performed and multivariable logistic regression models were constructed in order to define clinical and dermoscopic factors independently associated with each subtype. To validate our findings, two experienced dermoscopists not previously involved in the study were asked to evaluate clinical and dermoscopic images from an external dataset, guessing the proper BCC subtype between infiltrative, nodular and superficial, before and after being provided with the study results. A total of 481 histopathologically proven BCCs (51.4% nodular, 33.9% superficial, and 14.8% infiltrative) were included. We found that infiltrative BCC mostly appeared on the head and neck as an amelanotic hypopigmented plaque or papule, displaying ulceration on dermoscopic examination, along with arborizing and fine superficial telangiectasia. Shiny white structures were also frequently observed. Multivariate regression analysis allowed us to define a clinical-dermoscopic profile of infiltrative BCC. We defined the clinical-dermoscopic profile of infiltrative BCC, allowing to differentiate this variant from superficial and nodular BCC. This will improve pre-surgical recognition of infiltrative forms, reducing the risk for post-surgical recurrence.

Sections du résumé

BACKGROUND BACKGROUND
Infiltrative basal cell carcinoma (BCC) has a higher risk for post-surgical recurrence as compared to the most common low-aggressive superficial and nodular BCC. Independent diagnostic criteria for infiltrative BCC diagnosis have not been still defined. Improving the pre-surgical recognition of infiltrative BCC might significantly reduce the risk of incomplete excision and recurrence.
OBJECTIVE OBJECTIVE
The aim of this study is to define clinical and dermoscopic criteria that can differentiate infiltrative BCC from the most common low-aggressive superficial and nodular BCC.
METHODS METHODS
Clinical and dermoscopic images of infiltrative, superficial, and nodular BCC were retrospectively retrieved from our database and jointly evaluated by two experienced dermoscopists, blinded for the histologic subtype. Pairwise comparisons between the three histologic subtypes were performed and multivariable logistic regression models were constructed in order to define clinical and dermoscopic factors independently associated with each subtype. To validate our findings, two experienced dermoscopists not previously involved in the study were asked to evaluate clinical and dermoscopic images from an external dataset, guessing the proper BCC subtype between infiltrative, nodular and superficial, before and after being provided with the study results.
RESULT RESULTS
A total of 481 histopathologically proven BCCs (51.4% nodular, 33.9% superficial, and 14.8% infiltrative) were included. We found that infiltrative BCC mostly appeared on the head and neck as an amelanotic hypopigmented plaque or papule, displaying ulceration on dermoscopic examination, along with arborizing and fine superficial telangiectasia. Shiny white structures were also frequently observed. Multivariate regression analysis allowed us to define a clinical-dermoscopic profile of infiltrative BCC.
CONCLUSIONS CONCLUSIONS
We defined the clinical-dermoscopic profile of infiltrative BCC, allowing to differentiate this variant from superficial and nodular BCC. This will improve pre-surgical recognition of infiltrative forms, reducing the risk for post-surgical recurrence.

Identifiants

pubmed: 33680953
doi: 10.3389/fonc.2020.630458
pmc: PMC7933517
doi:

Types de publication

Journal Article

Langues

eng

Pagination

630458

Informations de copyright

Copyright © 2021 Pampena, Parisi, Benati, Borsari, Lai, Paolino, Cesinaro, Ciardo, Farnetani, Bassoli, Argenziano, Pellacani and Longo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Am Acad Dermatol. 2014 Feb;70(2):303-11
pubmed: 24268311
J Plast Reconstr Aesthet Surg. 2017 Dec;70(12):1738-1745
pubmed: 28579037
J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1118-26
pubmed: 2273112
J Am Acad Dermatol. 2019 Jun;80(6):1755-1757
pubmed: 30003992
J Eur Acad Dermatol Venereol. 2019 May;33(5):e201-e203
pubmed: 30720895
J Am Acad Dermatol. 2010 Jan;62(1):67-75
pubmed: 19828209
Dermatology. 2019;235(1):35-44
pubmed: 30404078
Dermatology. 2017;233(6):482-488
pubmed: 29566370
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):79-87
pubmed: 32401364
J Am Acad Dermatol. 2019 Nov 7;:
pubmed: 31706938
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2090-2096
pubmed: 29633358
Br J Dermatol. 2016 Oct;175(4):751-61
pubmed: 26921200
Dermatol Pract Concept. 2014 Jul 31;4(3):11-24
pubmed: 25126452
J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1732-41
pubmed: 25627865
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e425-e427
pubmed: 32180282
J Am Acad Dermatol. 2014 Oct;71(4):716-724.e1
pubmed: 24928707
J Am Acad Dermatol. 2010 Sep;63(3):377-86; quiz 387-8
pubmed: 20708470

Auteurs

Riccardo Pampena (R)

Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Gabriele Parisi (G)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Mattia Benati (M)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Stefania Borsari (S)

Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Michela Lai (M)

Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Giovanni Paolino (G)

Unit of Dermatology, IRCCS Ospedale San Raffaele, Milano, Italy.
Clinica Dermatologica, La Sapienza University of Rome, Rome, Italy.

Anna Maria Cesinaro (AM)

Department of Pathological Anatomy, Modena University Hospital, Modena, Italy.

Silvana Ciardo (S)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Francesca Farnetani (F)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Sara Bassoli (S)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Giuseppe Argenziano (G)

Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Giovanni Pellacani (G)

Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Caterina Longo (C)

Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Classifications MeSH